Clinical Trial Update: Safety and Efficacy of FMT in Individuals With One or More Recurrences of Clostridium Difficile Associated Disease (CDAD) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on safety and efficacy of fecal microbiota transplantation (FMT) for individuals with recurrent Clostridium difficile-associated disease …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection
• Dysbiosis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Clostridial Infection, Dysbiosis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-05-02